Navigation Links
Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee
Date:7/7/2010

Stone Research Foundation Publishes Study Results in The British Journal of Bone & Joint Surgery, Showing a 9.9 Year Survival Rate. Success of Less Invasive Procedures for Knee Damage Could Help Lower Skyrocketing Instances of Knee Replacement Surgery

San Francisco, CA (PRWEB) July 7, 2010 -- Biologic knee repair, rather than bionic (artificial) replacement, may slow the progression of arthritis without limiting the option for future arthroplasty, according to a study by Kevin R. Stone, MD, chairman, the Stone Research Foundation in this month’s issue of The British Journal of Bone & Joint Surgery. These research results could have significant impact on the long-term feasibility of artificial knee replacement - the number of artificial joint replacement surgeries is predicted to increase to 3.4 million by 2030, with proportionate increases in cost. The goal of biologic knee repair, according to Dr. Stone, is to avoid or forestall knee replacement surgery.

The report is based on a study of 119 meniscal allograft transplantations performed concurrently with articular cartilage repair in 115 patients with severe articular cartilage damage. The Kaplan-Meier estimated mean survival time for the whole series was 9.9 years. Loss of the meniscus generates increased forces on the articular cartilage of the knee and other joint structures and increases the risk of the development of arthritis. The appropriate treatment for loss of the meniscus with unicompartmental arthritis remains controversial, with treatments including osteotomy, unicompartmental (UKR) or total knee replacement. The study was approved by an independent Institutional Review Board. The study abstract is available via The British Journal of Bone & Joint Surgery.

Co-authors of the study with Dr. Stone are Ann W. Walgenbach, RNNP; Wendy Adelson, MS; Jonathan Pelsis, MHP; and Tom Turek of The Stone Research Foundation, San Francisco.

About The Stone Research Foundation:
The Stone Research Foundation is an independent, public, non-profit research institute based in San Francisco. Its mission is to research and develop ways to prevent, treat, and reverse arthritis and joint injuries. More info is available at www.stoneresearch.org.

###

Read the full story at http://www.prweb.com/releases/2010/07/prweb4231024.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Combination MMRV vaccine linked with 2-fold risk of seizures
2. Noninvasive combination technique may reduce number of breast biopsies
3. New combination effective against pancreatic cancer
4. Combination treatment regimen not effective against advanced melanoma
5. Combination therapy targets stubborn leukemia stem cells
6. Hair Loss Doctor Overcomes Odds To Produce First Ever Combination Topical Hair Growth Formula
7. Combination antibiotics effective against chlamydia-induced arthritis
8. Leeza Gibbons and ZERONA Equals a Winning Combination
9. Researchers find new chemotherapy combination shows promise in endometrial cancer
10. Combination Treatment May Help Depressed Alcoholics
11. Combination therapy more effective for enlarged prostate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee 
(Date:4/26/2017)... St. Louis, Missouri (PRWEB) , ... April 26, ... ... optimal cost, quality and clinical outcomes, today released the podcast, “Make Plans ... Act in bringing value-based payment into the physician's office and how physicians and ...
(Date:4/26/2017)... N.J. (PRWEB) , ... April 26, 2017 , ... ... Inc. in Hackensack, N.J. has been honored by Enterprising Women magazine as ... that recognizes the world’s top women business owners. Winners have demonstrated that they ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced plant ... produce more and better food, with fewer resources. It highlights the business’ principles, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , ... . This new addition to the Mirroring360 product family combines device screen mirroring ... Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror app ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
Breaking Medicine Technology: